Vicente Coutinho MD 🇧🇷
3.1K posts

Vicente Coutinho MD 🇧🇷
@doctorvpc
20y experience general physician - Primary care / Hormone replacement therapy . Boxer 🥊 .






Nattokinase isn’t high on my list for cardiovascular prevention. I don’t see convincing evidence that it should be a primary strategy for cardiovascular disease or stroke risk reduction. If the goal is cardiovascular prevention, there are options with much stronger support. Omega-3 fatty acids (EPA + DHA) have far better evidence. And if we’re talking specifically about atherosclerosis, berberine has a much more compelling evidence base—it’s been shown to reduce plaque formation, while also improving LDL, HbA1c, and glucose regulation. Nattokinase may be interesting mechanistically, but right now the clinical evidence just isn’t strong enough for me to view it as a serious front-line strategy.




@igorserafini_ Valeu Igor nocaute round 3 na sua call 100 conto no bolso do pai



I think we’ll see a lot of people do a mix of tirzepatide and retatrtutide Leverage a lower dose of Reta for the metabolic effects without going too high and a low to moderate dose of tirz for stronger appetite suppression When we treat blood pressure we often use lower doses of 2+ meds -> less side effects of each and more of a synergistic therapeutic effect. This concept likely extends to obesity I wonder if Lily will make a combo of the two


Davi Brito EVOLUIU MUITO no boxe















